Trade Teladoc Health, Inc. - TDOC CFD

Add to favourite

12.86

2.06%

0.13

Low: 12.84

High: 13.04

Market Trading Hours* (UTC) Open now
Closes on Friday at 20:00

Mon - Fri: 13:30 - 20:00

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.13

Long position overnight fee

-0.026179%

Short position overnight fee

0.003957%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

Stock exchange

United States of America

Commission on trade

*Information provided by Capital.com

Teladoc Health Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	13.12
Open*	13.02
1-Year Change*	-52.27%
Day's Range*	12.84 - 13.04
52 wk Range	15.02-34.36
Average Volume (10 days)	3.79M
Average Volume (3 months)	97.01M
Market Cap	3.29B
P/E Ratio	-100.00K
Shares Outstanding	165.56M
Revenue	2.58B
EPS	-24.66
Dividend (Yield %)	N/A
Beta	1.01
Next Earnings Date	Feb 20, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	13.12	0.14	1.08%	12.98	13.29	12.87
Apr 17, 2024	13.07	-0.05	-0.38%	13.12	13.44	13.04
Apr 16, 2024	13.06	-0.21	-1.58%	13.27	13.42	13.03
Apr 15, 2024	13.49	-0.52	-3.71%	14.01	14.10	13.31
Apr 12, 2024	14.16	-0.22	-1.53%	14.38	14.54	14.15
Apr 11, 2024	14.53	-0.05	-0.34%	14.58	14.73	14.19
Apr 10, 2024	14.43	0.09	0.63%	14.34	14.62	14.30
Apr 9, 2024	15.01	0.43	2.95%	14.58	15.12	14.54
Apr 8, 2024	14.56	0.09	0.62%	14.47	14.63	14.38
Apr 5, 2024	14.43	0.45	3.22%	13.98	14.65	13.53
Apr 4, 2024	14.18	-0.28	-1.94%	14.46	14.68	14.18
Apr 3, 2024	14.34	0.24	1.70%	14.10	14.40	13.99
Apr 2, 2024	14.27	-0.18	-1.25%	14.45	14.45	14.15
Apr 1, 2024	14.79	-0.29	-1.92%	15.08	15.21	14.50
Mar 28, 2024	15.03	-0.29	-1.89%	15.32	15.37	15.00
Mar 27, 2024	15.20	0.16	1.06%	15.04	15.21	14.99
Mar 26, 2024	14.98	-0.22	-1.45%	15.20	15.25	14.89
Mar 25, 2024	15.02	0.01	0.07%	15.01	15.15	14.95
Mar 22, 2024	14.93	-0.21	-1.39%	15.14	15.28	14.89
Mar 21, 2024	15.22	-0.28	-1.81%	15.50	15.62	15.20

Teladoc Health, Inc. Events

Time (UTC)	Country	Event
Wednesday, April 24, 2024
Time (UTC) 10:59	Country US	Event Q1 2024 Teladoc Health Inc Earnings Release Q1 2024 Teladoc Health Inc Earnings Release Forecast - Previous -
Thursday, May 23, 2024
Time (UTC) 18:00	Country US	Event Teladoc Health Inc Annual Shareholders Meeting Teladoc Health Inc Annual Shareholders Meeting Forecast - Previous -
Friday, May 24, 2024
Time (UTC) 18:00	Country US	Event Teladoc Health Inc Annual Shareholders Meeting Teladoc Health Inc Annual Shareholders Meeting Forecast - Previous -
Tuesday, July 23, 2024
Time (UTC) 10:59	Country US	Event Q2 2024 Teladoc Health Inc Earnings Release Q2 2024 Teladoc Health Inc Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	2406.84	2032.71	1093.96	553.307	417.907
Revenue	2406.84	2032.71	1093.96	553.307	417.907
Cost of Revenue, Total	743.987	650.258	390.829	184.465	128.735
Gross Profit	1662.85	1382.45	703.133	368.842	289.172
Total Operating Expense	16060.1	2342.09	1609.46	633.749	488.761
Selling/General/Admin. Expenses, Total	1300.56	1105.31	886.882	339.068	265.16
Research & Development	333.629	311.884	164.941	64.644	54.373
Depreciation / Amortization	256.027	204.239	69.495	38.952	35.602
Unusual Expense (Income)	13425.8	70.391	97.313	6.62	4.891
Operating Income	-13653.2	-309.379	-515.498	-80.442	-70.854
Interest Income (Expense), Net Non-Operating	-9.27	-80.365	-60.495	-29.013	-26.112
Net Income Before Taxes	-13663.3	-384.656	-575.993	-109.455	-96.966
Net Income After Taxes	-13659.5	-428.793	-485.136	-98.864	-97.084
Net Income Before Extra. Items	-13659.5	-428.793	-485.136	-98.864	-97.084
Net Income	-13659.5	-428.793	-485.136	-98.864	-97.084
Income Available to Common Excl. Extra. Items	-13659.5	-428.793	-485.136	-98.864	-97.084
Income Available to Common Incl. Extra. Items	-13659.5	-428.793	-485.136	-98.864	-97.084
Diluted Net Income	-13659.5	-428.793	-485.136	-98.864	-97.084
Diluted Weighted Average Shares	161.457	156.939	90.5092	71.8445	65.8449
Diluted EPS Excluding Extraordinary Items	-84.6016	-2.73223	-5.36007	-1.37608	-1.47443
Diluted Normalized EPS	-30.5513	-2.44069	-4.66121	-1.31619	-1.42615
Total Extraordinary Items
Other, Net	-0.859	5.088

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total revenue	660.238	652.406	629.244	637.709	611.402
Revenue	660.238	652.406	629.244	637.709	611.402
Cost of Revenue, Total	185.96	190.54	190.107	188.873	185.619
Gross Profit	474.278	461.866	439.137	448.836	425.783
Total Operating Expense	724.963	724.051	706.346	4453.26	683.132
Selling/General/Admin. Expenses, Total	354.177	358.127	345.425	324.243	346.096
Research & Development	84.289	87.309	86.985	77.576	87.815
Depreciation / Amortization	94.302	75.465	69.783	75.715	62.008
Unusual Expense (Income)	6.235	12.61	14.046	3786.85	1.594
Operating Income	-64.725	-71.645	-77.102	-3815.55	-71.73
Interest Income (Expense), Net Non-Operating	6.96	5.723	3.648	1.893	-1.346
Other, Net	-1.792	-0.207	4.907	1.748	-1.571
Net Income Before Taxes	-59.557	-66.129	-68.547	-3811.91	-74.647
Net Income After Taxes	-57.073	-65.177	-69.228	-3810.07	-73.476
Net Income Before Extra. Items	-57.073	-65.177	-69.228	-3810.07	-73.476
Net Income	-57.073	-65.177	-69.228	-3810.07	-73.476
Income Available to Common Excl. Extra. Items	-57.073	-65.177	-69.228	-3810.07	-73.476
Income Available to Common Incl. Extra. Items	-57.073	-65.177	-69.228	-3810.07	-73.476
Diluted Net Income	-57.073	-65.177	-69.228	-3810.07	-73.476
Diluted Weighted Average Shares	165.119	164.171	162.923	162.177	161.728
Diluted EPS Excluding Extraordinary Items	-0.34565	-0.39701	-0.42491	-23.4932	-0.45432
Dividends per Share - Common Stock Primary Issue	0	0	0		0
Diluted Normalized EPS	-0.3211	-0.34708	-0.36887	-8.31568	-0.44791

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	1315.39	1225.44	1059.61	588.002	532.736
Cash and Short Term Investments	918.182	896.017	786.569	517.064	478.534
Cash & Equivalents	918.182	893.48	733.324	514.353	423.989
Short Term Investments	0	2.537	53.245	2.711	54.545
Total Receivables, Net	235.645	168.956	169.281	56.948	43.571
Accounts Receivable - Trade, Net	210.554	168.956	169.281	56.948	43.571
Prepaid Expenses	63.159	87.387	47.259	13.99	10.631
Total Assets	4345.35	17734.6	17755.3	1602.83	1528.88
Property/Plant/Equipment, Total - Net	71.472	74.014	75.198	36.748	10.148
Property/Plant/Equipment, Total - Gross	119.184	108.144	97.163	52.51	22.431
Accumulated Depreciation, Total	-47.712	-34.13	-21.965	-15.762	-12.283
Goodwill, Net	1073.19	14504.2	14581.3	746.079	737.197
Intangibles, Net	1836.77	1910.28	2020.86	225.453	247.394
Other Long Term Assets, Total	48.54	20.703	18.357	6.545	1.401
Total Current Liabilities	399.769	331.013	332.649	90.181	62.439
Accounts Payable	47.69	47.257	46.03	9.075	7.769
Accrued Expenses	193.44	162.009	156.066	57.785	41.212
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	11.375	13.313	56.013
Other Current Liabilities, Total	147.264	108.434	74.54	23.321	13.458
Total Liabilities	2037.61	1688.85	1871.48	588.802	515.757
Total Long Term Debt	1543.37	1234.96	1389.52	440.41	414.683
Long Term Debt	1543.37	1234.96	1389.52	440.41	414.683
Deferred Income Tax	50.939	75.777	102.103	21.678	32.444
Other Liabilities, Total	43.532	47.099	47.207	36.533	6.191
Total Equity	2307.75	16045.8	15883.8	1014.03	1013.12
Common Stock	0.163	0.16	0.15	0.073	0.07
Additional Paid-In Capital	17358.6	17473.3	16857.8	1538.72	1434.78
Retained Earnings (Accumulated Deficit)	-15008.3	-1421.45	-992.661	-507.525	-408.661
Other Equity, Total	-42.776	-6.285	18.518	-17.239	-13.07
Total Liabilities & Shareholders’ Equity	4345.35	17734.6	17755.3	1602.83	1528.88
Total Common Shares Outstanding	162.84	160.469	150.281	72.7619	70.5163
Total Inventory	56.342	73.079	56.498
Other Current Assets, Total	42.06

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total Current Assets	1387.09	1320.96	1286.71	1315.39	1287.59
Cash and Short Term Investments	1030.53	958.695	888.579	918.182	899.631
Cash & Equivalents	1030.53	958.695	888.579	918.182	899.631
Short Term Investments				0	0
Total Receivables, Net	218.741	227.444	241.08	210.554	201.701
Accounts Receivable - Trade, Net	205.866	215.181	215.981	210.554	201.701
Total Inventory	35.916	34.054	45.801	56.342	59.344
Prepaid Expenses	62.248	62.103	77.526	130.31	126.912
Total Assets	4327.97	4316.4	4309.15	4345.35	8103.96
Property/Plant/Equipment, Total - Net	64.938	65.216	69.309	71.472	72.457
Goodwill, Net	1073.19	1073.19	1073.19	1073.19	4846
Intangibles, Net	1728.3	1784.1	1815.95	1836.77	1854.26
Other Long Term Assets, Total	74.452	72.93	63.993	48.54	43.656
Total Current Liabilities	402.64	383.394	381.344	399.769	411.401
Accounts Payable	25.998	16.071	38.625	47.69	70.783
Accrued Expenses	224.739	208.116	192.872	193.44	202.633
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases			11.247	11.375	10.086
Other Current Liabilities, Total	151.903	159.207	138.6	147.264	127.899
Total Liabilities	2033.92	2021.26	2017.92	2037.61	2051.3
Total Long Term Debt	1537.83	1536.98	1544.17	1543.37	1542.3
Long Term Debt	1537.83	1536.98	1544.17	1543.37	1542.3
Deferred Income Tax	44.252	48.097	50.613	50.939	51.742
Other Liabilities, Total	49.198	52.789	41.793	43.532	45.858
Total Equity	2294.05	2295.14	2291.23	2307.75	6052.66
Common Stock	0.166	0.165	0.164	0.163	0.162
Additional Paid-In Capital	17535.2	17476.5	17409.6	17358.6	17300
Retained Earnings (Accumulated Deficit)	-15199.8	-15142.7	-15077.5	-15008.3	-11198.2
Other Equity, Total	-41.52	-38.78	-40.997	-42.776	-49.266
Total Liabilities & Shareholders’ Equity	4327.97	4316.4	4309.15	4345.35	8103.96
Total Common Shares Outstanding	165.557	164.877	163.919	162.84	162.196
Other Current Assets, Total	39.659	38.668	33.721

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	-13659.5	-428.793	-485.136	-98.864	-97.084
Cash From Operating Activities	189.292	193.99	-53.511	29.869	-4.86
Cash From Operating Activities	258.886	204.239	71.192	44.952	35.602
Deferred Taxes	-7.84	41.8	-90.158	-10.868	-2.247
Non-Cash Items	13658.7	427.068	541.074	94.805	59.999
Cash Interest Paid	17.361	16.43	14.89	12.224	10.303
Changes in Working Capital	-60.971	-50.324	-90.483	-0.156	-1.13
Cash From Investing Activities	-167.743	-72.981	-590.975	25.013	-257.496
Capital Expenditures	-172.764	-63.934	-26.042	-10.9	-8.407
Other Investing Cash Flow Items, Total	5.021	-9.047	-564.933	35.913	-249.089
Cash From Financing Activities	6.497	40.947	859.136	35.094	645.612
Financing Cash Flow Items	-2.741	-0.73	-36.703	-1.569	1.721
Issuance (Retirement) of Stock, Net	12.385	42.591	59.036	36.663	364.729
Issuance (Retirement) of Debt, Net	-3.147	-0.914	836.803	0	279.162
Foreign Exchange Effects	-3.344	-1.8	4.321	0.388	-2.084
Net Change in Cash	24.702	160.156	218.971	90.364	381.172
Cash Taxes Paid	2.512	3.974	1.324	1.31	0.441

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Net income/Starting Line	-69.228	-13659.5	-9849.46	-9775.98	-6674.52
Cash From Operating Activities	13.156	189.292	123.743	60.722	-31.747
Cash From Operating Activities	70.464	258.886	182.497	119.79	59.703
Deferred Taxes	-0.355	-7.84	-5.942	-2.528	-2.319
Non-Cash Items	55.451	13658.7	9821.4	9755.49	6669.03
Cash Taxes Paid	0.346	2.512	0.901	0.564	0.261
Cash Interest Paid	0.194	17.361	8.688	8.673	0.007
Changes in Working Capital	-43.176	-60.971	-24.756	-36.048	-83.634
Cash From Investing Activities	-45.624	-167.743	-113.852	-72.404	-27.567
Capital Expenditures	-45.624	-172.764	-118.873	-75.668	-30.831
Other Investing Cash Flow Items, Total	0	5.021	5.021	3.264	3.264
Cash From Financing Activities	3.353	6.497	2.116	1.482	2.816
Financing Cash Flow Items	0.499	-2.741	-2.253	-2.794	-2.76
Issuance (Retirement) of Stock, Net	3.027	12.385	9.032	6.952	7.265
Issuance (Retirement) of Debt, Net	-0.173	-3.147	-4.663	-2.676	-1.689
Foreign Exchange Effects	-0.488	-3.344	-5.856	-2.119	-0.538
Net Change in Cash	-29.603	24.702	6.151	-12.319	-57.036

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Teladoc Health, Inc. Company profile

Teladoc Health Inc provides virtual healthcare services on a business-to-business basis in the US and internationally. According to the company, it’s the largest telehealth platform in the US.

The company looks to provide fast, remotely accessible and affordable healthcare. Teladoc connects customers with over 1,100 board-certified physicians and behavioural health professionals, delivering on-demand healthcare via the internet on video or phone.

Teladoc Health serves numerous corporations, health plans, health systems and other entities. The company generates revenue via subscriptions and per visit fees.

The company provides point-of-care devices and solutions – Viewpoint Cart, TV Pro, Xpress Cart, Vantage and Vita – to hospitals for patient care and monitoring. Teladoc Health also offers its products and services under the brands Teladoc, InTouch Health, Livongo, BetterHelp, MedecinDirect and HealthiestYou.

Jason Gorevic has been the company’s chief executive since 2009. The company was initially known as Teladoc. It was renamed Teladoc Health in August 2018. Teladoc Health was incorporated in 2002. It’s headquartered in Purchase, New York.

Industry:

Telemedicine Services

2 Manhattanville Rd Ste 203
PURCHASE
NEW YORK 10577-2118
US

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024